Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016)

Fulgent Genetics (FLGT) posted Cash from Discontinued Operations of 14000.0 for Q2 2016, up 17.65% sequentially from 17000.0 in Q1 2016.

Fulgent Genetics (FLGT) Cash from Discontinued Operations (2015 - 2016) Analysis & Trends

Fulgent Genetics (FLGT) has 2 years of Cash from Discontinued Operations data on file, last reported at 14000.0 in Q2 2016.

Quarterly Cash from Discontinued Operations changed N/A year-over-year to 14000.0 in Q2 2016, while the trailing twelve-month figure through Dec 2016 was 31000.0 (changed N/A YoY) and the FY2016 annual result came in at 31000.0, up 98.96% from the prior year.
Cash from Discontinued Operations climbed to 14000.0 in Q2 2016 per FLGT's latest filing, from 17000.0 in the prior quarter.
The five-year high for Cash from Discontinued Operations was 14000.0 in Q2 2016, with the low at 916000.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Discontinued Operations (Qtr)
1	Waters	31,055.11 Bn	31,054.65 Bn	1.11 Bn	-
2	Thermo Fisher Scientific	191.02 Bn	187.77 Bn	7.74 Bn	-
3	Danaher	137.16 Bn	131.47 Bn	3.59 Bn	-
4	Idexx Laboratories	42.82 Bn	42.62 Bn	722.74 Mn	-
5	Natera	39.09 Bn	37.99 Bn	696.04 Mn	-
6	Agilent Technologies	37.61 Bn	35.81 Bn	990.00 Mn	-
7	Iqvia Holdings	34.23 Bn	32.25 Bn	1.36 Bn	-
8	Illumina	28.14 Bn	26.98 Bn	721.00 Mn	-
9	Mettler Toledo International	26.40 Bn	26.33 Bn	555.82 Mn	-
10	Fulgent Genetics	642.94 Mn	360.99 Mn	21.49 Mn	-

Download Data